Skip to main content
Fig. 1 | BMC Veterinary Research

Fig. 1

From: Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells

Fig. 1

Cell viability after 72-h treatment with increasing doses of rapamycin, everolimus and carboplatin. Cell viability was measured by the crystal violet assay as described in the methods section. The error bars represent mean +/− SD of 3 experiments conducted in technical triplicate. IC50, half-maximal inhibitory concentration; mTOR, mechanistic target of rapamycin

Back to article page